Andrew R. Mullen
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 10%
- Biochemistry top 2%
- Physiology top 10%
- Co-authors
- Ralph J. DeBerardinisNavdeep S. ChandelTzuling ChengEunsook S. JinLucas B. SullivanYoufeng YangWilliam W. WheatonPei-Hsuan Chen
- Topics
- Cancer, Hypoxia, and Metabolism (10 papers)Mitochondrial Function and Pathology (3 papers)Cancer Research and Treatments (3 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Andrew R. Mullen
15 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 2.1k
- Cancer Research 1.7k
- Oncology 252
- Biochemistry 251
- Physiology 212
Countries citing papers authored by Andrew R. Mullen
This map shows the geographic impact of Andrew R. Mullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Mullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Mullen more than expected).
Fields of papers citing papers by Andrew R. Mullen
This network shows the impact of papers produced by Andrew R. Mullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Mullen. The network helps show where Andrew R. Mullen may publish in the future.
Co-authorship network of co-authors of Andrew R. Mullen
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew R. Mullen. A scholar is included among the top collaborators of Andrew R. Mullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew R. Mullen. Andrew R. Mullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 259 | |
| 3 | 28 | |
| 4 | 6 | |
| 5 | 239 | |
| 6 | 52 | |
| 7 | 255 | |
| 8 | 64 | |
| 9 | Reductive carboxylation supports growth in tumour cells with defective mitochondriabreakdown → | 1004 |
| 10 | 153 | |
| 11 | 375 | |
| 12 | 62 | |
| 13 | 82 | |
| 14 | 88 | |
| 15 | 151 |
About Andrew R. Mullen
Andrew R. Mullen is a scholar working on Cancer Research, Biochemistry and Biotechnology, having authored 15 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (10 papers), Mitochondrial Function and Pathology (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (1.7k citations), Biochemistry (251 citations) and Molecular Biology (2.1k citations). Andrew R. Mullen has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Ralph J. DeBerardinis, Navdeep S. Chandel, Tzuling Cheng, Eunsook S. Jin, Lucas B. Sullivan, Youfeng Yang, William W. Wheaton, Pei-Hsuan Chen, W. Marston Linehan and José M. Matés. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.